
How long should anticoagulation continue after an apparently successful atrial fibrillation ablation? Should prophylactic pulmonary vein isolation be added during typical atrial flutter ablation in patients with heart failure? What do emerging data reveal about neurologic events, hemolysis, and renal safety with pulsed-field ablation?In EP Edge® Journal Watch Issue 33, August 2026, Dr. Sharma provides a clinically focused and thought-provoking review of nine important cardiac electrophysiology studies published in Heart Rhythm and JACC: Clinical Electrophysiology.This episode examines: The proposed 8.1-month timing for oral anticoagulant discontinuation after successful AF ablation Prophylactic pulmonary vein isolation in patients with typical atrial flutter and heart failure Lesion delivery, irrigation rates, and neurovascular events with pulsed-field ablation PFA-associated hemolysis, acute kidney injury, and platform-specific renal safety Transvenous lead extraction outcomes in patients with prior sternotomy First-in-human vibration-based lead extraction The line-of-block pacing maneuver for distinguishing AV nodal from accessory pathway conduction The SCAAF-ERS electrocardiographic score for sudden cardiac arrest risk in atrial fibrillation A gain-of-function KCNJ8 variant linked with inherited and acquired J-wave syndromes Rather than simply listing study results, Dr. Sharma explains why each investigation was needed, what clinical uncertainty it attempted to resolve, how the methodology affects interpretation, and what the principal statistics mean in practical terms. Each paper concludes with the EP Edge Take, including the potential implications for current practice, the limitations that should temper interpretation, and the questions that future research must answer.The episode also includes updates on the EP Edge® app, the new epedge.org website, and the upcoming EP Edge® Journal Watch collaboration with the Heart Rhythm Society.Full references, study graphics, and the complete written analysis are available through the EP Edge® Journal Watch newsletter on LinkedIn and on Substack at epedge.substack.com.Questions, suggestions, or concerns can be sent to epedge.cast@gmail.com.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

EP Edge Journal Watch 36: ESC 2026, AF Ablation and Sham Trials | PVI-SHAM-AF, PFA-SHAM, SHAM-PVI, FlexPulse, NEXAF, IDEAL-AF, ENRICH-AF

EP Edge Journal Watch Issue 35: ESC 2026 Munich Special Edition | SINGLE-AF, CMR GUIDE, New HF Guidelines & Fifth Universal Definition of MI

EP Edge × HRS: Rethinking the Defaults: AFib Ablation vs Antiarrhythmics, Flecainide Beyond CAST, and Physiologic Pacing

EP Edge Journal Watch Issue 34 August 2026: ICD Shocks, Troponin, PFA Safety, LOSE-AF Weight Loss and POTS, Radiation Expose in the EP Lab
Free AI-powered recaps of EP Edge Journal Watch: Cardiac Electrophysiology Research and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.